A phase I/IIa trial of ATX MS 1467 in patients with secondary progressive multiple sclerosis.
Phase of Trial: Phase I/II
Latest Information Update: 10 Mar 2008
At a glance
- Drugs ATX MS 1467 (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Apitope Technology
- 10 Mar 2008 New trial record.
- 05 Nov 2007 Initial results reported by Apitope Technology; full results expected Q1 2008.